Smoking behavior following diagnosis in patients with Stage I non-small cell lung cancer

Gritz, Ellen R.; Nisenbaum, Rosane; Elashoff, Robert; Holmes, E. Carmack

doi:10.1007/bf00053129

Cited by 130 publications

(124 citation statements)

References 20 publications

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…However, whereas estimates of quitting around the time of diagnosis are in the range of 35%-79% [49,50], about one third of nonadvanced-stage lung cancer patients resume smoking within the first year after surgery [50 -52]. Dr. Park and colleagues examined data from the Cancer Care Outcomes Research and Surveillance cohort survey and reported that 90% of lung cancer patients had a history of ever smoking and approximately one third of lung cancer patients reported smoking around the time of diagnosis [53].…”

Section: Lung Cancer Patients Who Continue To Smoke May Be Vulnerablementioning

confidence: 99%

“…Dr. Park and colleagues examined data from the Cancer Care Outcomes Research and Surveillance cohort survey and reported that 90% of lung cancer patients had a history of ever smoking and approximately one third of lung cancer patients reported smoking around the time of diagnosis [53]. It is important to note that many participants reported quitting tobacco use prior to, during, and immediately following a cancer diagnosis, resulting in a significant group of lung cancer patients who were relatively new former smokers and thus vulnerable to smoking relapse [50].…”

Section: Lung Cancer Patients Who Continue To Smoke May Be Vulnerablementioning

confidence: 99%

“…Most lung cancer patients who smoke want to quit smoking [49,50] but need help in order to do so. In the 2 years following a lung cancer diagnosis, 86.4% of smokers try to quit [50].…”

Section: Lung Cancer Patients Particularly Blacks Are a Vulnerable mentioning

confidence: 99%

“…In the 2 years following a lung cancer diagnosis, 86.4% of smokers try to quit [50]. Recently, the American Society for Clinical Oncology's Quality Oncology Practice Initiative included among its core measures that: (a) cigarette smoking status be documented by the second medical visit and (b) tobacco treatment counseling be recommended to patients receiving cancer treatment [89].…”

Section: Lung Cancer Patients Particularly Blacks Are a Vulnerable mentioning

confidence: 99%

See 3 more Smart Citations

Disparities Between Blacks and Whites in Tobacco and Lung Cancer Treatment

et al. 2011

View full text Add to dashboard Cite

Racial disparities exist in lung cancer incidence, morbidity, and mortality. Smoking is responsible for the majority of lung cancers, and racial disparities also exist in smoking outcomes. Black smokers are less likely than white smokers to engage in evidence-based tobacco treatment, and black smokers are less likely than white smokers to stop smoking. Continued smoking following a lung cancer diagnosis is a potential indicator of poor lung cancer treatment outcomes, yet lung cancer patients who smoke are unlikely to receive evidence-based tobacco treatment. The risks from continued smoking after diagnosis deserve attention as a modifiable factor toward lessening racial disparities in lung cancer outcomes.

show abstract

Section: Lung Cancer Patients Who Continue To Smoke May Be Vulnerablementioning

confidence: 99%

Section: Lung Cancer Patients Who Continue To Smoke May Be Vulnerablementioning

confidence: 99%

“…Most lung cancer patients who smoke want to quit smoking [49,50] but need help in order to do so. In the 2 years following a lung cancer diagnosis, 86.4% of smokers try to quit [50].…”

Section: Lung Cancer Patients Particularly Blacks Are a Vulnerable mentioning

confidence: 99%

Section: Lung Cancer Patients Particularly Blacks Are a Vulnerable mentioning

confidence: 99%

See 2 more Smart Citations

Disparities Between Blacks and Whites in Tobacco and Lung Cancer Treatment

et al. 2011

View full text Add to dashboard Cite

show abstract

“…5 For example, in a study of 317 smokers diagnosed with Mountain 6 Stage I nonsmall cell lung carcinoma (NSCLC), researchers found a 12-month tobacco abstinence rate of 53% and a 24-month tobacco abstinence rate of 47%. 7 Others have reported an 86% tobacco abstinence rate after thoracotomy for resection of a pulmonary malignancy. 8 Despite the importance of providing smoking cessation interventions for individuals either diagnosed with lung carcinoma or for those considered to be at high risk for developing lung carcinoma, this is an underinvestigated area.…”

mentioning

confidence: 99%

Change in smoking status after spiral chest computed tomography scan screening

Cox¹,

Clark²,

Jett³

et al. 2003

Cancer

View full text Add to dashboard Cite

BACKGROUNDCancer screening may provide a “teachable moment” for the reduction of high‐risk behaviors. The current study evaluated smoking behavior changes in current and former smokers after low‐dose, fast spiral chest computed tomography scan (CT) screening for lung carcinoma.METHODSThe study was comprised of 901 current smokers and 574 former smokers who participated in a low‐dose, fast spiral chest CT scan screening study for lung carcinoma. Demographic, pulmonary function, screening recommendations, and smoking history variables were evaluated as predictors of self‐reported point prevalence smoking abstinence 1 year after screening.RESULTSOf the current smokers at baseline, 14% reported smoking abstinence at follow‐up. Older age and poorer lung function were associated with smoking abstinence. Ninety percent of former smokers reported smoking abstinence at a 1‐year of follow‐up. A longer duration of smoking abstinence at baseline was found to be predictive of abstinence in this group.CONCLUSIONSThe 14% smoking abstinence rate was higher than would be expected for spontaneous rates of smoking cessation. Therefore, screening may provide a teachable moment for smokers. Low‐dose, fast spiral chest CT scan screening recommendations were not found to be associated with smoking behavior change in either group. Further research is needed to evaluate the potential avenues through which lung carcinoma screening can be used as an opportunity for providing effective nicotine interventions. Cancer 2003. © 2003 American Cancer Society.

show abstract

Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma

Khariwala

Hatsukami

Stepanov

et al. 2018

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

IMPORTANCE Among smokers with head and neck squamous cell carcinoma (HNSCC), there is ample evidence regarding the benefits of smoking cessation prior to treatment. Prior data indicates that increased attempts at cessation result in higher likelihood of cessation after diagnosis but the prediagnostic patterns of smoking cessation attempts among those smokers developing HNSCC has not been characterized. Data of this kind may direct cessation efforts toward increased efficacy.OBJECTIVE To determine the frequency and character of tobacco cessation attempts and symptoms experienced prior to development of HNSCC, as well as to determine the correlation of these symptoms with number of cessation attempts and maximum quit days. DESIGN, SETTING, AND PARTICIPANTSCross-sectional study including 123 active smokers with HNSCC recruited from a tertiary medical center at an academic institution from February 2014 to May 2017.EXPOSURES All included patients were active cigarette smokers prior to developing HNSCC. MAIN OUTCOMES AND MEASURESPatients provided data indicating intensity of smoking, duration, number of cessation attempts, maximum number of days during which they successfully ceased smoking, and symptoms during cessation attempts. Principal component analysis was used to identify clustering of symptoms. Overall, 108 patients (88%) had made at least 1 prior attempt at cessation, and the mean number of lifetime cessation attempts was 6.6. Symptoms of cravings, restlessness, irritability, and anxiety were reported most frequently. Symptoms were clustered into 2 component groups: component group 1 (C1; increased appetite, cravings, depression) and component group 2 (C2; restlessness, irritability, insomnia, anxiety, and difficulty concentrating). Component group 2 correlated with quit attempts (Spearman correlation, 0.268 [95% CI, 0.07 to 0.45]), and C1 and C2 were not correlated with maximum quit days. Cessation attempts and maximum quit days positively correlated with each other.CONCLUSIONS AND RELEVANCE Our analysis shows that symptoms during cessation attempts tend to cluster and that most patients made 1 or more cessation attempts. Many patients successfully ceased before restarting. Our data suggest that patients experiencing C2 symptoms make more quit attempts; C1 symptoms may be more difficult to overcome because they are associated with fewer quit attempts. Future work will address whether amelioration of these symptoms may help smoking cessation among smokers with HNSCC.

show abstract

Smoking behavior following diagnosis in patients with Stage I non-small cell lung cancer

Cited by 130 publications

References 20 publications

Disparities Between Blacks and Whites in Tobacco and Lung Cancer Treatment

Disparities Between Blacks and Whites in Tobacco and Lung Cancer Treatment

Change in smoking status after spiral chest computed tomography scan screening

Patterns of Tobacco Cessation Attempts and Symptoms Experienced Among Smokers With Head and Neck Squamous Cell Carcinoma

Contact Info

Product

Resources

About